Migraine
Not recruitingStudy on Rimegepant for Treating Migraine in Adults Who Cannot Use Triptans
- Disease:Migraine
- Substances:Rimegepant
Germany- Participants:18–64 years · 65+ years
- Substances:Rimegepant
- Sponsor:Pfizer Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany93 clinical trials in Wiesbaden, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials exploring treatments for chronic respiratory diseases, including studies on new therapies for COPD and various forms of chronic rhinosinusitis.
Research focuses on improving symptom control and patient quality of life through targeted therapies.
Comprehensive studies investigating breakthrough treatments for various cancers, with particular emphasis on breast cancer and endometrial cancer therapies.
Trials evaluate novel therapeutic approaches and combination treatments to improve patient outcomes.
Studies examining treatments for long-term health conditions, including chronic kidney disease, hypertension, and multiple sclerosis.
Research aims to develop more effective treatments and improve disease management strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.